According to Mark Rosenberg, DO, St. Joseph’s Regional Medical Center’s chairman of the department of emergency medicine, the goal of the ALTO program is to try and treat most patients without opioids before considering using them.
During the first two months of the ALTO program, 300 patients participated, 75 percent of whom did not need opioids. The program did not include patients with cancer or those with chronic pain who are already dependent on opioids.
Andrew Kolodny, MD, executive director of Physicians for Responsible Opioid Prescribing, commented on the success of the ALTO program at St. Joseph’s.
“I think it is unique that they’re going to do a variety of measures to avoid using opioids,” Dr. Kolodny told the Post. “In many cases, we’re exposing people to opioids when we don’t need to be.”
The key, according to Dr. Rosenberg, is to get patients over the first 24 to 48 hours of pain with tools such as nerve blocks and non-opioid pain relievers such as acetaminophen.
“If I can get you over that, you’re going to feel a lot better,” Dr. Rosenberg told the Post.
More articles on opioids:
Opioid-related hospital visits almost doubled since 2007 in Mass.
99% percent of primary care physicians overprescribe addictive painkillers
UT Medical Center study supports opiate detox during pregnancy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
